Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback